相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
Sarah Shigdar et al.
PHARMACEUTICS (2022)
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
Luis Exequiel Ibarra et al.
PHARMACEUTICS (2022)
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G. Earnest et al.
SCIENTIFIC REPORTS (2021)
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
Lisa Agnello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
Cancers Ipilimuma et al.
CANCERS (2020)
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Simona Camorani et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Gennaro Sanita et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review
Gayathri Ravichandran et al.
ACS APPLIED NANO MATERIALS (2020)
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer
Simona Camorani et al.
ISCIENCE (2020)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
Gloria V. Echeverria et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing
Margherita Passariello et al.
CANCERS (2019)
Prediction of the secondary structure of short DNA aptamers
Arina Afanasyeva et al.
BIOPHYSICS AND PHYSICOBIOLOGY (2019)
Aptamers: Uptake mechanisms and intracellular applications
Sorah Yoon et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani et al.
THERANOSTICS (2018)
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
Simona Camorani et al.
PHARMACEUTICALS (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
Simona Camorani et al.
SCIENTIFIC REPORTS (2017)
Practical Approach to Triple-Negative Breast Cancer
Vijayakrishna K. Gadi et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Post-SELEX optimization of aptamers
Shunxiang Gao et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Highly stable aptamers selected from a 2′-fully modified fGmH RNA library for targeting biomaterials
Adam D. Friedman et al.
BIOMATERIALS (2015)
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer
Lisa A. Newman et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Determination of minimal sequence for binding of an aptamer. A comparison of truncation and hybridization inhibition methods
Thao T. Le et al.
RSC ADVANCES (2014)
The Smart Targeting of Nanoparticles
Adam Friedman et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
RNA aptamers that functionally interact with green fluorescent protein and its derivatives
Bo Shui et al.
NUCLEIC ACIDS RESEARCH (2012)
Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling
William M. Rockey et al.
NUCLEIC ACID THERAPEUTICS (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
Bioinformatic analysis of the contribution of primer sequences to aptamer structures
Matthew C. Cowperthwaite et al.
JOURNAL OF MOLECULAR EVOLUTION (2008)
Optimization and modifications of aptamers selected from live cancer cell lines
Dihua Shangguan et al.
CHEMBIOCHEM (2007)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
A comprehensive comparison of comparative RNA structure prediction approaches
PP Gardner et al.
BMC BIOINFORMATICS (2004)
DNA as a 'nanomaterial'
Y Ito et al.
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC (2004)
Developing aptamers into therapeutics
RR White et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
